Interpace Diagnostics: Falls on $7 mln stock deal

Interpace Biosciences

25/01/2019 12:22

** Interpace Diagnostics  IDXG.O  down 20 pct premarket as
cancer diagnostics co raises $7 mln of equity 
    ** Stock among biggest losers across U.S. exchanges at 7:15
am ET
    ** Co offers 9.33 mln shares at $0.75, 17 pct discount to
stock's Thurs close  urn:newsml:reuters.com:*:nGNX87GF9y
    ** Offering represents a third of co's free float and
roughly a month's worth of trading volume, per Refinitiv data
    ** H.C. Wainwright sole bookrunner for offering
    ** IDXG shares have fallen 17 pct over past one year
    

 ((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 646-223-5017))